Ellodi Pharmaceuticals

$4.5M revenue • 25 employees • 325 Sentry Parkway, Blue Bell, PA, 19422, United States

Last Updated Mar 20, 2025

Company Overview

Company Name

Ellodi Pharmaceuticals

Address

325 Sentry Parkway, Blue Bell, PA, 19422, United States

Approx. Annual Revenue

$4.5M

Employees

25

Established

2020

About Ellodi Pharmaceuticals

Ellodi Pharmaceuticals is a biopharmaceutical company headquartered in Blue Bell, PA, United States. The company is focused on developing innovative therapies for eosinophilic esophagitis, with a pipeline that includes the investigational drug APT-1011 currently in the FLUTE 3 clinical study. Ellodi Pharmaceuticals is committed to collaborating with patient advocacy groups to address the unmet medical needs of individuals affected by this chronic condition.

More Companies in Pennsylvania

Browse all companies in Pennsylvania →

Frequently Asked Questions about Ellodi Pharmaceuticals

Categories

Technologies Used

Key Decision Makers

David Strunk Sr. Clinical Trial Manager
LinkedIn